Discoid Lupus Erythematosus - Articles

Sort by: Newest Most Comments Relevance

Discoid Lupus Erythematosus (DLE) Problem by heru m. Patient Expert

Posted Fri 13 Feb 2009 4:52pm could be taken? All and any advice appreciated. Thank you Answer: Hi Tony, What you describe is likely to be a Discoid Lupus Erythematosus (DLE). Despite the long and scary...-discoid-lupus-image/ I hope this re-assures you. Best wishes, Julien ShareThis Read on »

Systemic sclerosis (scleroderma) associated with discoid lupus erythematosus. by Jan Posted Sun 29 Aug 2010 12:00am Six patients with systemic sclerosis (SS) and discoid lupus erythematosus (DLE) were studied to determine whether such cases have some common clinical and laboratory... had DLE on the face and extremities. No case fulfilled criteria for systemic lupus erythematosus (SLE). The present cases with SS and DLE, but without SLE, indicate Read on »

A Potential New Treatment for Severe Discoid Lupus by Duane P. Patient Expert

Posted Thu 28 May 2009 10:12pm Discoid lupus is a form of lupus that affects the skin (cutaneous lupus). In most cases the discoid lupus rash appears on the face, neck, or scalp, though it can also show up on other areas of the skin. Severe discoid lupus may result in scarring. The treatments that are used most often for severe discoid lupus are strong immunosuppressants that may have Read on »

A Potential New Treatment for Severe Discoid Lupus by Wick D. Posted Thu 28 May 2009 5:46am Discoid lupus is a form of lupus that affects the skin (cutaneous lupus). In most cases the discoid lupus rash appears on the face, neck, or scalp, though it can also show up on other areas of the skin. Severe discoid lupus may result in scarring. The treatments that are used most often for severe discoid lupus are strong immunosuppressants that may have Read on »

Coping with Lupus: Fact #16 – Discoid is the most common lupus by Lupus Adventurer Posted Wed 16 May 2012 11:00am Coping with Lupus: Discoid lupus (the most common form of skin lupus) accounts for approximately 10 percent of all cases of lupus and occurs in 20 percent of those with systemic lupus. My discoid lupus was most pronounced before I began taking Plaquenil, and after this first baseline drug treatment started, my rashes cleared up on my face, e ... Read on »

Systemic lupus erythematosus (SLE) by Ahmad.H Posted Fri 03 Dec 2010 12:00am SLE is a chronic disease that causes inflammation of connective tissue. It is a multisystem autoimmune inflammatory disease. SLE is the commonest and the most serious type of lupus. What causes SLE ? SLE is believed to be an autoimmune disease, which means that the body's immune system produce antibodies that attacks the own ... Read on »

New Data Shows Epratuzumab Provided Significant Efficacy for Patients with Moderate to Severe Systemic Lupus Erythematosus by Duane P. Patient Expert

Posted Wed 16 Jun 2010 9:02am UCB and Immunomedics Inc. announced today that a new lupus drug candidate, epratuzumab, provided a significant reduction in disease activity in patients with moderate to severe active systemic lupus erythematosus (SLE). Findings demonstrate that in a patient population with predominantly severe disease activity, epratuzumab is improving patients Read on »

Anxiety News: Anxiety And Depression Lower Quality Of Life In Majority Of Systemic Lupus Erythematosus Patients by Katie G. Healthy Living Professional

Posted Wed 17 Jun 2009 6:31pm Anxiety And Depression Lower Quality Of Life In Majority Of Systemic Lupus Erythematosus Patients ScienceDaily (June 12, 2009) — 92.8% of patients with systemic lupus erythematosus (SLE) suffer anxiety and depression which significantly affects both their physical and emotional quality of life (QoL), according to the results of a new study presented Read on »

New Data Shows Epratuzumab Provided Significant Efficacy for Patients with Moderate to Severe Systemic Lupus Erythematosus by Wick D. Posted Wed 16 Jun 2010 12:10pm UCB and Immunomedics Inc. announced today that a new lupus drug candidate, epratuzumab, provided a significant reduction in disease activity in patients with moderate to severe active systemic lupus erythematosus (SLE). Findings demonstrate that in a patient population with predominantly severe disease activity, epratuzumab is improving Read on »

UCB and Immunomedics announce positive results for epratuzumab phase IIb study in systemic lupus erythematosus (SLE) by Duane P. Patient Expert

Posted Mon 31 Aug 2009 10:08pm

1 Comment with systemic lupus. The data showed that the 12-week dose response and the dose frequency study of epratuzumab in patients with moderate to severe active lupus demonstrated a clinically meaningful treatment effect showing the drug was more effective than placebo in reducing symptoms of lupus. “The LFA congratulates UCB and Immunomedics on the positive results from Read on »

Related Discussions

Benlysta.... thoughts...?

Name that skin condition...

Houston Lab disarms AIDS virus

When to Suspect Lyme

Fatigue is a Signal

Discoid Lupus Erythematosus

Discoid Lupus Erythematosus - Articles

Related Searches

Related Discussions